Previous 10 | Next 10 |
Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced that it will report its first quarter 2020 financial results after the market close on Tuesday, April 28, 2020. The Company will host a conference call the following morning, Wednesday, April 29, 2020, at 9:00 a.m....
Business disruptions due to COVID-19 represent a new risk for investors across all sectors. Expect to see language addressing this added to the risk factors section of 10-K annual reports filed with the Securities and Exchange Commission (SEC). For biotech and pharma companies, COVID-19 will im...
Image source: The Motley Fool. Medpace Holdings, Inc. (NASDAQ: MEDP) Q4 2019 Earnings Call Feb 25, 2020 , 9:00 a.m. ET Operator Continue reading
Medpace Holdings, Inc. (MEDP) Q4 2019 Earnings Conference Call February 25, 2020, 09:00 AM ET Company Participants Kevin Brady - Executive Director of Finance August Troendle - President and CEO Jesse Geiger - CFO and COO of Laboratory Operations Conference Call Participants ...
The following slide deck was published by Medpace Holdings, Inc. in conjunction with their 2019 Q4 earnings Read more ...
Medpace (NASDAQ: MEDP ): Q4 Non-GAAP EPS of $0.85 beats by $0.10 ; GAAP EPS of $0.78 beats by $0.08 . More news on: Medpace Holdings, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Revenue of $229.9 million in the fourth quarter of 2019 increased 19.7% from revenue of $192.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.7%; Full year 2019 revenue of $861.0 million increased 22.2% from full year 2018. Net new busines...
Medpace Holdings ( MEDP ) is a medical diagnostics and research firm that provides clinical development services to biotech, pharmaceutical, and medical device companies. The company is based in Cincinnati, Ohio and was founded in 1992. The stock price for Medpace has more than doubled in the ...
Relmada Therapeutics (NASDAQ: RLMD ) initiated with Buy rating and $75 (73% upside) price target at Jefferies. More news on: Relmada Therapeutics, Inc., Biogen Inc., Denali Therapeutics Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2019 financial results after the market close on Monday, February 24, 2020. The Company will host a conference call the following morning, Tuesday, February 2...
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
Medpace Holdings Inc. Website:
Revenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $551.0 million in the second quarter of 2024, representing a decrease ...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...